(±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14)

(±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14) is a deuterated form of tolterodine tartrate, which is a medication used to treat symptoms related to an overactive bladder. It works by blocking certain receptors in the bladder muscles, which reduces the urge to urinate and helps to control incontinence. The deuterated form of tolterodine tartrate is used in pharmacological research and studies to determine the drug's pharmacokinetics and metabolism. Chemically, (±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14) is a deuterated form of tolterodine tartrate, which is a racemic mixture of R- and S-isomers. The molecular formula of (±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14) is C26H37D14NO8, and its molecular weight is 595.73 g/mol. It is a white to off-white crystalline powder that is soluble in water and slightly soluble in ethanol. The recommended dosage of (±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14) varies depending on the patient's age, medical condition, and response to treatment. It is typically administered orally once or twice daily, with or without food. Common side effects of tolterodine tartrate include dry mouth, constipation, blurred vision, and dizziness. In rare cases, it may cause serious side effects such as difficulty breathing, severe allergic reactions, or irregular heartbeats. Overall, (±)-Tolterodine-d14 Tartrate (di-iso-propyl-d14) is a useful tool in pharmacological research to better understand the pharmacokinetics and metabolism of tolterodine tartrate, which ultimately helps to improve patient care and treatment outcomes.